Lithoz collaborates with Metoxit and Dr Jens Tartsch to produce 3D-printed ceramic dental implants

Lithoz GmbH, provider of world-leading technology for the 3D printing of high-performance ceramics, has started a strategic collaboration with Metoxit and Dr Jens Tartsch, combining their developments for a project to produce ceramic dental implants via additive manufacturing.

Using Lithography-based Ceramic Manufacturing, it will be possible to quickly and efficiently produce high-strength dental implants which are biocompatible and available in a range of sizes and shapes.

Metoxit, a Swiss high-tech ceramics company, develops and produces innovative oxide ceramics of the highest quality, with a focus on precision medical implants as well as high-performance components for mechanical and electrical engineering applications.

With more than 43 years of experience in the field, Metoxit has been a key innovator in ceramic medical applications over the years, both in the areas of hip joint implants and dental applications.

Dr Tartsch, who runs a private dental clinic in Zürich, Switzerland, is the founder and president of the European Society for Ceramic Implantology ESCI and member of Board of Directors of the Swiss Society for Anti-Aging Medicine and Prevention (SSAAMP).

His main focus is ceramic implant dentistry, as well as biomaterial and immunological aspects in dentistry and material incompatibilities.

The cooperation of these industry leaders with Austrian-based Lithoz to manufacture dental implants is a new step forward in the field of ceramic 3D printing for medical and dental applications. 

In modern dentistry, dental implants play an important role in the reconstruction and restoration of missing teeth in partially or completely edentulous patients. Aesthetics, comfort, and biocompatible materials are of the utmost importance when it comes to treating such patients.

Their implants must possess good bone ingrowth capabilities and need to be able to withstand the high levels of daily stress placed on them. Thus, the absence of defects such as pores or cracks is even more important than with any other ceramic parts. 

Lithoz’s Lithography-based Ceramic Manufacturing (LCM) technology is intended to ensure that such requirements are met when it comes to producing dental implants.

LCM is an efficient and tool-free process—it does not require moulds as with other conventional manufacturing techniques and therefore allows for the production of far more complex structures when compared to other methods.

The number of manufacturing steps involved is significantly reduced, with intricate features such as inner threads and surface modifications being carried out during the 3D printing process itself. This ensures that the production process is not only reliable but also highly cost-effective. 

Components produced via LCM fit suitably to the restored crown and have high mechanical strength, while the ceramic materials used by Lithoz for these applications also have biocompatible properties and facilitate good adhesion between the bone and implant.

This method also allows for a broad variety of shapes and sizes when manufacturing these dental components, ensuring every need can be met for different patients. 

Lithoz’s systems have been specially designed for LCM techniques and this technology will aid Metoxit in providing the highest level of quality and safety for dental patients. Both companies will benefit greatly from the expert knowledge Dr Jens Tartsch will bring to the project with his almost 30 years of experience.

As Dr Tartsch stated, “This collaboration will result in a joint research project that will optimise the use of 3D printing processes and LCM technology for producing ceramic dental implants, making them suitable for broad range of applications in the future.”

The integration of further strategic partners and scientific institutions is planned.